Literature DB >> 17425379

Protocol for the examination of specimens from pediatric patients with hepatoblastoma.

Milton J Finegold1, Dolores H Lopez-Terrada, Jay Bowen, Mary Kay Washington, Stephen J Qualman.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17425379     DOI: 10.5858/2007-131-520-PFTEOS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  12 in total

Review 1.  Neonatal tumours.

Authors:  Kokila Lakhoo; Helen Sowerbutts
Journal:  Pediatr Surg Int       Date:  2010-10-19       Impact factor: 1.827

Review 2.  The efficient operation of the surgical pathology gross room.

Authors:  W C Bell; E S Young; P E Billings; W E Grizzle
Journal:  Biotech Histochem       Date:  2008-04       Impact factor: 1.718

3.  Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.

Authors:  Xiaodong Xie; Haitao Zhu; Jia Zhang; Meiqin Wang; Li Zhu; Zhen Guo; Wenrong Shen; Dongqing Wang
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

4.  Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Authors:  Marcio H Malogolowkin; Howard M Katzenstein; Rebecka L Meyers; Mark D Krailo; Jon M Rowland; Joel Haas; Milton J Finegold
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

5.  Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.

Authors:  Katalin Dezso; Judit Halász; Hanne Cathrine Bisgaard; Sándor Paku; Eszter Turányi; Zsuzsa Schaff; Peter Nagy
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

Review 6.  International pediatric liver cancer pathological classification: current trend.

Authors:  Yukichi Tanaka; Takeshi Inoue; Hiroshi Horie
Journal:  Int J Clin Oncol       Date:  2013-10-18       Impact factor: 3.402

7.  The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.

Authors:  Elizabeth Stewart; Sara Federico; Asa Karlstrom; Anang Shelat; Andras Sablauer; Alberto Pappo; Michael A Dyer
Journal:  Dev Biol       Date:  2015-06-09       Impact factor: 3.582

Review 8.  The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.

Authors:  Daniel C Aronson; Piotr Czauderna; Rudolf Maibach; Giorgio Perilongo; Bruce Morland
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

9.  Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center.

Authors:  Luis A Caicedo; Angie Sabogal; Oscar Serrano; Jorge I Villegas; Verónica Botero; María T Agudelo; Viviana Lotero; Diana Dávalos; Eliana Manzi; Ana M Aristizabal; Catalina Gomez; Gabriel J Echeverri
Journal:  Transplant Direct       Date:  2017-05-25

10.  Glypican 3 as a Serum Marker for Hepatoblastoma.

Authors:  Shengmei Zhou; Maurice R G O'Gorman; Fusheng Yang; Kevin Andresen; Larry Wang
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.